These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-005266-37 Influence of Escitalopram on the incidence of depression and dementia following acute middle cerebral artery territory infarction. A randomized, placebo-controlled, double blind study. not-yet-due
Ongoing 2006-007090-72 The role of the glutamatergic system in the extinction of conditioned reinforcement processes not-yet-due
Exempt 2007-002245-20 Evaluation of potential central glucoregulatory compounds to treat/ameliorate the symptoms of schizophrenia: a proof-of-concept study in healthy volunteers not-yet-due
Ongoing 2007-004286-18 Monocentric, Double-blind Placebo-Controlled, Randomized Cross-Sectional Clinical Trial of Hydrocortisone (10 and 30mg/d) in Outpatients with Posttraumatic-Stress- Disorder (PTSD) not-yet-due
Ongoing 2007-004309-90 Fahrtüchtigkeit bei Erwachsenen mit Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS) vor und nach 10wöchiger Behandlung mit 40-80 mg Atomoxetin im Vgl. zu unbehandelten Erwachsenen mit ADHS not-yet-due
Ongoing 2012-004079-38 Agomelatine treatment of major depressive episodes in the course of schizophrenic psychoses (AGOPSYCH). not-yet-due
Ongoing 2012-004335-23 A four-week, multicentre, double-blinded, randomised, active- and placebo-controlled, parallel-group trial investigating efficacy and safety of cannabidiol in acute, early-stage schizophrenic patients... not-yet-due
Completed, report not yet due 2018-001212-30 A trial to study effects of a single dose Citalopram on emotion processing in female patients with Borderline Personality Disorder and the associated modulation of fMRI BOLD signals 2019-10-22 not-yet-due